You are viewing the site in preview mode

Skip to main content
Fig. 3 | Journal of Pharmaceutical Health Care and Sciences

Fig. 3

From: Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes

Fig. 3

Long-term changes of CYP3A4 activity and serum clarithromycin or its metabolite concentrations. Time course of serum concentration of clarithromycin (CAM, ○) and 14-hydroxy-CAM (M-5, △), and the ratio of urinary 6β-hydroxycortisol/cortisol (6βOHF/F, ♦) up to the day 365 (n = 4, mean ± SE)

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us